» Articles » PMID: 15179668

Polyunsaturated Fatty Acid Levels in Red Cell Membranes of Unmedicated Schizophrenic Patients

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 2004 Jun 5
PMID 15179668
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

There are several reports of reduced levels of polyunsaturated fatty acids (PUFA), particularly arachidonic acid (AA) and docosahexaenoic acid (DHA), in membrane phospholipid from various tissues including red blood cells (RBC) taken from schizophrenic patients. However, reports have not been entirely consistent and most studies have been confounded by the potential effects of environmental factors including antipsychotic medication and diet. We measured PUFA levels in RBC from two separate groups of unmedicated patients and control subjects from India and Malaysia, populations which have substantial differences in diet. We found no significant difference in levels of AA between patients and control subjects in either population. Levels of adrenic acid were significantly reduced, and levels of DHA significantly increased in both clinical populations. However, diet-related differences in DHA between the populations from India and Malaysia were much greater than differences between schizophrenic patients and controls. It is concluded that reduced RBC membrane levels of AA and DHA are not pathognomic of schizophrenia but that variations in cell membrane fatty acid levels are an epiphenomenon which may reflect underlying abnormalities of phospholipid and fatty acid metabolism and their interaction with environmental factors including medication and diet.

Citing Articles

Compare and Contrast of the Cellular Actions of Related Flavonoids, Apigenin and Chrysin.

Keefe P, Puthanveetil P Nutrients. 2024; 16(23).

PMID: 39683588 PMC: 11644185. DOI: 10.3390/nu16234195.


Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis.

Susai S, Healy C, Mongan D, Heurich M, Byrne J, Cannon M Transl Psychiatry. 2022; 12(1):454.

PMID: 36307392 PMC: 9616837. DOI: 10.1038/s41398-022-02217-0.


Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship.

Yu Y, Su H, Lin S, Hsiao P, Lin Y, Liu C Schizophrenia (Heidelb). 2022; 8(1):38.

PMID: 35853900 PMC: 9261101. DOI: 10.1038/s41537-022-00252-w.


Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.

Hsu M, Huang Y, Ouyang W Lipids Health Dis. 2020; 19(1):159.

PMID: 32620164 PMC: 7333328. DOI: 10.1186/s12944-020-01337-0.


Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.

Kageyama Y, Kasahara T, Nakamura T, Hattori K, Deguchi Y, Tani M Int J Neuropsychopharmacol. 2017; 21(3):207-215.

PMID: 29040586 PMC: 5838832. DOI: 10.1093/ijnp/pyx089.